MedPath

Prevalence of Colon Cancer in Pyogenic Liver Abscess

Completed
Conditions
Cryptogenic Pyogenic Liver Abscess
Registration Number
NCT02032914
Lead Sponsor
Inje University
Brief Summary

Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Pyogenic liver abscess radiologically and bacteriologically diagnosed
Exclusion Criteria
  • Amebic liver abscess
  • Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
  • Refusal to colonoscopic examination
  • Inadequate general patient status to perform the colonoscopic examination
  • Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The prevalence of colonic neoplasmwithin 6 weeks after diagnosis of pyogenic liver abscess
Secondary Outcome Measures
NameTimeMethod
Prevalence of intestinal tuberculosisWithin 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of colonic diverticulitisWithin 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of inflammatory bowel diseaseWithin 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of colon polypWithin 6 weeks at diagnosis of pyogenic liver abscess

Trial Locations

Locations (2)

Pusan National Unversity Yangsan Hospital

🇰🇷

Yangsan-si, Gyeongsangnam-do, Korea, Republic of

Inje University Haeundae Paik Hospital

🇰🇷

Busan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath